1. Home
  2. A vs ALC Comparison

A vs ALC Comparison

Compare A & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • A
  • ALC
  • Stock Information
  • Founded
  • A 1999
  • ALC 1945
  • Country
  • A United States
  • ALC Switzerland
  • Employees
  • A N/A
  • ALC N/A
  • Industry
  • A Biotechnology: Laboratory Analytical Instruments
  • ALC Ophthalmic Goods
  • Sector
  • A Industrials
  • ALC Health Care
  • Exchange
  • A Nasdaq
  • ALC Nasdaq
  • Market Cap
  • A 38.6B
  • ALC 44.0B
  • IPO Year
  • A 1999
  • ALC N/A
  • Fundamental
  • Price
  • A $116.70
  • ALC $95.78
  • Analyst Decision
  • A Buy
  • ALC Buy
  • Analyst Count
  • A 13
  • ALC 12
  • Target Price
  • A $151.50
  • ALC $104.90
  • AVG Volume (30 Days)
  • A 2.1M
  • ALC 1.4M
  • Earning Date
  • A 02-26-2025
  • ALC 05-12-2025
  • Dividend Yield
  • A 0.85%
  • ALC 0.28%
  • EPS Growth
  • A 4.31
  • ALC 4.59
  • EPS
  • A 4.36
  • ALC 2.05
  • Revenue
  • A $6,533,000,000.00
  • ALC $9,911,000,000.00
  • Revenue This Year
  • A $5.84
  • ALC $6.19
  • Revenue Next Year
  • A $6.23
  • ALC $7.00
  • P/E Ratio
  • A $26.77
  • ALC $46.54
  • Revenue Growth
  • A N/A
  • ALC 4.82
  • 52 Week Low
  • A $116.36
  • ALC $77.54
  • 52 Week High
  • A $155.35
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • A 29.80
  • ALC 61.36
  • Support Level
  • A $117.92
  • ALC $90.64
  • Resistance Level
  • A $124.43
  • ALC $97.40
  • Average True Range (ATR)
  • A 2.97
  • ALC 1.31
  • MACD
  • A 0.26
  • ALC 0.53
  • Stochastic Oscillator
  • A 4.15
  • ALC 84.79

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: